Form 4: Intuitive Surgical Insider Trades ISRG Stock

Jeddi Iman, SVP & GM da Vinci Platforms & at Intuitive Surgical Inc., reported transactions involving common stock and stock options on June 1, 2026, under a Rule 10b5-1 trading plan.

Summary

• Jeddi Iman, Senior Vice President & General Manager of da Vinci Platforms & at Intuitive Surgical Inc. (ISRG), executed a series of transactions on June 1, 2026.
• These transactions were conducted under a pre-arranged trading plan designed to comply with SEC Rule 10b5-1, which provides an affirmative defense against insider trading allegations.
• The plan is set to expire on June 5, 2026.
• Iman acquired 5,625 shares of common stock at a price of $76.9989 per share.
• Concurrently, Iman disposed of 5,625 shares of common stock at a price of $420.55 per share.
• Following these transactions, Iman beneficially owns 6,463 shares of common stock directly, and an additional 26,649 shares indirectly through a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves significant share transactions by a senior executive, these were conducted under a pre-approved Rule 10b5-1 trading plan, mitigating concerns about opportunistic insider trading.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, indicating a structured and pre-planned approach to insider stock transactions, which can mitigate insider trading concerns.
• The acquisition of shares at a lower price ($76.9989) and disposal at a higher price ($420.55) suggests a profitable execution within the trading plan.
• The reporting person continues to hold a significant number of shares (6,463 directly and 26,649 indirectly), indicating continued investment in the company.

Negatives

• The disposal of 5,625 shares of common stock represents a reduction in the reporting person's direct holdings.
• The acquisition price of $76.9989 is substantially lower than the disposal price of $420.55, which could be interpreted as the reporting person selling shares at a significant profit, though this is within the framework of the trading plan.

Risks

• The Rule 10b5-1 trading plan has a short expiration date (June 5, 2026), which might indicate a need for future adjustments or a lack of long-term commitment to the current trading strategy.
• While executed under a plan, the disposal of a significant number of shares by a senior executive could be perceived negatively by the market, despite its pre-planned nature.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions executed under a trading plan.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by a senior executive at Intuitive Surgical, a leader in robotic-assisted minimally invasive surgery, is common practice to manage personal investments while adhering to securities regulations.

Corporate Governance

Stakeholder Impact

• Shareholders: The disposal of shares by a senior executive, even under a plan, might be scrutinized. However, the continued indirect ownership through a trust suggests ongoing commitment.
• Employees: The transactions do not directly impact employees but reflect the company's stock performance and executive compensation structure.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The Rule 10b5-1 trading plan expires on June 5, 2026.
• Future transactions by Jeddi Iman will be subject to further reporting requirements if they occur.

Key Dates

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Rule 10b5-1, Stock Options, Beneficial Ownership, Jeddi Iman, Stock Transaction, SEC Filing